方舟生物医药 ABIO 深 沪
已收盘 08-30 16:00:00 美东时间
2.40
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 2.40
- 总市值 3458.42万
- 52周最高 4.49
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.54
- 委 比 0.00%
- 总股本 1441.01万
- 历史最高 1852.20
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.10
- 每 手 1
- 风险率 0.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Oruka Therapeutics Completes Merger with ARCA Biopharma, Begins Trading Under ORKA, Appoints CRISPR CEO as Chairman
Oruka Therapeutics, Inc. ("Oruka") (NASDAQ:ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque psoriasis, today announced the completion of its previously announced merger with ARCA biopharma, Inc. The ...
2024-09-03 19:06
ARCA Biopharma Closes Merger With Oruka Therapeutics
06:03 PM EDT, 08/29/2024 (MT Newswires) -- ARCA Biopharma (ABIO) said late Thursday that it completed its merger with Oruka Therapeutics following a stockholder approval at a special meeting on Aug. 22. In addition, the combined company will implement a reverse stock split at a ratio of 1-for-12 sha...
2024-08-30 06:03
Reported Earlier, ARCA Biopharma Updates Special Dividend To $1.613/Share In Preparation For Oruka Therapeutics Merger
ARCA biopharma updates the previously announced final amount of the special cash dividend (the "Special Dividend"), which will now equal $1.613 per share of ARCA's common stock, payable on August 28, 2024, to ARCA's stockholders of record as of August 26, 2024. The Special Dividend was declared by A...
2024-08-27 15:30
ARCA biopharma to Implement 1-For-12 Reverse Stock Split
04:49 PM EDT, 08/23/2024 (MT Newswires) -- ARCA biopharma (ABIO) said Friday its board approved a 1-for-12 reverse stock split of its shares. The shares will start trading on a split-adjusted basis on Sept. 3 under the new name, Oruka Therapeutics, and under the new symbol "ORKA" following the expec...
2024-08-24 04:49
ARCA biopharma Announces 1-For-12 Reverse Stock Split In Connection With The Proposed Merger With Oruka Therapeutics; To Begin Trading On A Post-reverse Stock Split Basis On The Nasdaq Global Market On September 3, 2024, And Under The New Symbol "ORKA"
ARCA biopharma, Inc. (NASDAQ:ABIO) ("ARCA") today announced that its Board of Directors (the "Board") has approved a reverse stock split of ARCA's common stock at a ratio of 1-for-12. ARCA's common stock is expected to begin trading on a post-reverse stock split basis on The Nasdaq Global Market on ...
2024-08-24 04:31
ARCA biopharma to Distribute Special Dividend Conditional on Shareholder Approval of Oruka Therapeutics Merger
04:59 PM EDT, 08/16/2024 (MT Newswires) -- ARCA biopharma (ABIO) said late Friday that it will distribute a special dividend estimated to be $1.59 per share, subject to approval of the proposed merger with Oruka Therapeutics by ARCA shareholders. The exact amount of the dividend will be based on the...
2024-08-17 04:59
